Franklin Resources’s ARS Pharmaceuticals SPRY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $31.9M | Sell |
1,828,755
-28,789
| -2% | -$502K | 0.01% | 770 |
|
2025
Q1 | $23.4M | Sell |
1,857,544
-118,868
| -6% | -$1.5M | 0.01% | 852 |
|
2024
Q4 | $20.9M | Sell |
1,976,412
-860,840
| -30% | -$9.08M | 0.01% | 900 |
|
2024
Q3 | $42.4M | Sell |
2,837,252
-113,711
| -4% | -$1.7M | 0.01% | 660 |
|
2024
Q2 | $25.1M | Hold |
2,950,963
| – | – | 0.01% | 779 |
|
2024
Q1 | $30.2M | Sell |
2,950,963
-1,147,534
| -28% | -$11.7M | 0.01% | 736 |
|
2023
Q4 | $22.5M | Buy |
4,098,497
+229,988
| +6% | +$1.26M | 0.01% | 728 |
|
2023
Q3 | $14.6M | Buy |
+3,868,509
| New | +$14.6M | 0.01% | 824 |
|
2021
Q3 | – | Sell |
-224,208
| Closed | -$6.93M | – | 2493 |
|
2021
Q2 | $6.93M | Buy |
224,208
+24,200
| +12% | +$748K | ﹤0.01% | 1074 |
|
2021
Q1 | $8.73M | Hold |
200,008
| – | – | ﹤0.01% | 999 |
|
2020
Q4 | $9.27M | Buy |
+200,008
| New | +$9.27M | ﹤0.01% | 974 |
|